$34.65
3.75% yesterday
Nasdaq, Nov 15, 10:02 pm CET
ISIN
US79957L1008
Symbol
SMTI

Sanara MedTech Inc Stock price

$34.65
+2.51 7.81% 1M
+0.59 1.73% 6M
-6.45 15.69% YTD
+1.04 3.09% 1Y
+1.05 3.13% 3Y
+23.45 209.38% 5Y
+27.65 395.00% 10Y
Nasdaq, Closing price Fri, Nov 15 2024
-1.35 3.75%
ISIN
US79957L1008
Symbol
SMTI
Sector

Key metrics

Market capitalization $302.88m
Enterprise Value $318.19m
P/E (TTM) P/E ratio negative
EV/FCF (TTM) EV/FCF negative
EV/Sales (TTM) EV/Sales 4.08
P/S ratio (TTM) P/S ratio 3.88
P/B ratio (TTM) P/B ratio 7.61
Revenue growth (TTM) Revenue growth 24.66%
Revenue (TTM) Revenue $78.06m
EBIT (operating result TTM) EBIT $-8.45m
Free Cash Flow (TTM) Free Cash Flow $-1.99m
Cash position $16.28m
EPS (TTM) EPS $-0.99
P/E forward negative
P/S forward 3.80
EV/Sales forward 3.99
Short interest 6.51%
Show more

Is Sanara MedTech Inc a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,897 stocks worldwide.

Sanara MedTech Inc Stock Analysis

Unlock Scores for Free

Analyst Opinions

1 Analyst has issued a forecast Sanara MedTech Inc:

1x Buy
100%

Analyst Opinions

1 Analyst has issued a forecast Sanara MedTech Inc:

Buy
100%

Financial data from Sanara MedTech Inc

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Sep '24
+/-
%
78 78
25% 25%
100%
- Direct Costs 12 12
2% 2%
15%
66 66
30% 30%
85%
- Selling and Administrative Expenses 66 66
29% 29%
85%
- Research and Development Expense 3.94 3.94
13% 13%
5%
-4.04 -4.04
17% 17%
-5%
- Depreciation and Amortization 4.41 4.41
22% 22%
6%
EBIT (Operating Income) EBIT -8.45 -8.45
0% 0%
-11%
Net Profit -8.36 -8.36
2% 2%
-11%

In millions USD.

Don't miss a Thing! We will send you all news about Sanara MedTech Inc directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Sanara MedTech Inc Stock News

Neutral
Seeking Alpha
2 days ago
Sanara MedTech Inc. (NASDAQ:SMTI ) Q3 2024 Earnings Conference Call November 13, 2024 9:00 AM ET Company Participants Ronald Nixon - Executive Chairman and CEO Seth Yon - President of Commercial Michael McNeil - Chief Financial Officer Sam Muppalla - Tissue Health Plus Conference Call Participants Ross Osborn - Cantor Fitzgerald Ian Cassel - MicroCapClub Chris Plahm - Tall Pines Capital John Si...
Neutral
GlobeNewsWire
3 days ago
FORT WORTH, TX, Nov. 12, 2024 (GLOBE NEWSWIRE) -- Sanara MedTech Inc. Based in Fort Worth, Texas, Sanara MedTech Inc. (“Sanara,” the “Company,” “we,” “our” or “us”) (Nasdaq: SMTI), a medical technology company focused on developing and commercializing transformative technologies to improve clinical outcomes and reduce healthcare expenditures in the surgical, chronic wound and skincare markets, ...
Neutral
GlobeNewsWire
16 days ago
FORT WORTH, TX, Oct. 31, 2024 (GLOBE NEWSWIRE) -- Sanara MedTech Inc. Based in Fort Worth, Texas, Sanara MedTech Inc. (“Sanara,” the “Company,” “we,” “our” or “us”) (NASDAQ: SMTI), a medical technology company focused on developing and commercializing transformative technologies to improve clinical outcomes and reduce healthcare expenditures in the surgical, chronic wound and skincare markets, ...
More Sanara MedTech Inc News

Company Profile

Sanara MedTech, Inc.engages in the development, marketing, and distribution of biotechnology products to physicians, hospitals, and clinics. It offers CellerateRX Surgical Activated Collagen Adjuvant and HemaQuell Resorbable Bone Hemostat. The company was founded in 1982 and is headquartered in Fort Worth, TX.

Head office United States
CEO Ron Nixon
Employees 107
Founded 1982
Website www.sanaramedtech.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today